IL18 and colitis: This pathway and associated inflammatory markers could be relevant in colitis as NLRP3 inflammasome activity (critical for caspase 1-dependent release of IL-1β and IL-18) in the CNS has been implicated in the exacerbation of neuroinflammation by DSS-induced colitis in aging mice [139, 181].